Company intelligence / Profile preview

Energenx Medical Ltd.

Shanghai, Shanghai Municipality, China

Ownership: Private
Development stage: Other

Overview

Energenx Medical is conducting clinical trials in China for the RheOx system, a pulsed electric field (PEF) device, targeting chronic bronchitis. The company received Green Channel approval from the Chinese regulator for expedited review and has enrolled the first patient in a China-based trial

Therapeutic areas: Pulmonology
Modalities: Device
Industry: Therapeutic Medical Devices

Partnerships

Galvanize Therapeutics (technology licensor and strategic partner)

Beyond the preview

Go deeper on Energenx Medical Ltd..

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Energenx Medical Ltd..

Explore the full profile